Duffy System

  • Helmut Schenkel-Brunner


Duffy is a polymorphic blood group system of which six characters are defined to date (Table 16.1) (1):
  • the two principal antigens, Fya (= FY1) [16,17] and Fyb (= FY2) [26]. Based on the presence or absence of these antigens four phenotypes have been defined — Fy(a+b-), Fy(a-b+), Fy(a+b+) (with frequencies in Europids of 0.195, 0.33, and 0.475, respectively), and Fy(a-b-). This last phenotype is the predominant phenotype in Negrids but exceedingly rare outside the black population;

  • the characters Fy3 (= FY3) [2], Fy5 (= FY5) [14], and Fy6 (= FY6) [45,51], being linked to the expression of Fya and Fyb antigens, are present on the red cells of all persons except those of the Fy(a-b-) phenotype. These antigens thus represent epitopes localised on discrete domains of the Duffy blood group substance;

  • Fy4 (= FY4) [4] is present on almost all samples of Fy(a-b-) erythrocytes and some Fy(a+b-) and Fy(a-b+) cells from Negrids; the status of this antigenic character within the Duffy system is not yet clear.


Blood Group Blood Group Antigen Plasmodium Knowlesi Blood Group System Human Blood Group 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams, J. H., Hudson, D. E., Torii, M., Ward, G. E., Wellems, T. E., Aikawa, M. & Miller, L. H. (1990): The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63, 141–153.PubMedCrossRefGoogle Scholar
  2. 2.
    Albrey, J. A., Vincent, E. E. R., Hutchinson, J., Marsh, W. L., Allen, F. H., Gavin, J. & Sänger, R. (1971): A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang. 20, 29–35.PubMedCrossRefGoogle Scholar
  3. 3.
    Baggiolini, M., Dewald, B. & Moser, B. (1994): lnterleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55, 97–179.PubMedCrossRefGoogle Scholar
  4. 4.
    Behzad, O., Lee, C. L., Gavin, J. & Marsh, W. L. (1973): A new anti-erythrocyte antibody in the Duffy system: anti-Fy4. Vox Sang. 24, 337–342.PubMedCrossRefGoogle Scholar
  5. 5.
    Bird, G. W. G. & Wingham, J. (1970): N-acetylneuraminic (sialic) acid and human blood group antigen structure. Vox Sang. 18, 240–243.PubMedCrossRefGoogle Scholar
  6. 6.
    Cedergren, B. & Giles, C. M. (1973): An Fyx Fyx individual found in Northern Sweden. Vox Sang. 24, 264–266.CrossRefGoogle Scholar
  7. 6A.
    Cartron, J. P. (1996): Vers une approche moléculaire de la structure, du polymorphisme et de la fonction des groupes sanguins. Transfus. Clin. Biol. 3, 181–210.PubMedCrossRefGoogle Scholar
  8. 7.
    Chaudhuri, A., Nielsen, S., Elkjaer, M. L., Zbrzezna, V., Fang, F. & Pogo, O. (1997): Detection of Duffy antigen in the plasma membrane and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 89, 701–712.PubMedGoogle Scholar
  9. 8.
    Chaudhuri, A., Polyakova, J., Zbrzezna, V. & Pogo, A. O. (1995): The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 85, 615–621.PubMedGoogle Scholar
  10. 9.
    Chaudhuri, A., Polyakova, J., Zbrzezna, V., Williams, K., Gulati, S. & Pogo, A. O. (1993): Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc. Natl. Acad. Sci. USA 90, 10793–10797.PubMedCrossRefGoogle Scholar
  11. 10.
    Chaudhuri, A., Zbrzezna, V., Johnson, C., Nichols, M., Rubinstein, P., Marsh, W. L. & Pogo, A. O. (1989): Purification and characterization of an erythrocyte membrane protein complex carrying Duffy blood group antigenicity. Possible receptor for Plasmodium vivax and Plasmodium knowiesi malaria parasite. J. Biol. Chem. 264, 13770–13774.PubMedGoogle Scholar
  12. 11.
    Chaudhuri, A., Zbrzezna, V., Polyakova, J., Pogo, A. O., Hesselgesser, J. & Horuk, R. (1994): Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J. Biol. Chem. 269, 7835–7835.PubMedGoogle Scholar
  13. 12.
    Chitnis, C. E., Chaudhuri, A., Horuk, R., Pogo, A. O. & Miller, L. H. (1996): The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowiesi malarial parasites to erythrocytes. J. Exp. Med. 184, 1531–1536.PubMedCrossRefGoogle Scholar
  14. 13.
    Chown, B., Lewis, M. & Kaita, H. (1965): The Duffy blood group system in Caucasians: evidence for a new allele. Am. J. Hum. Genet. 17, 384–389.PubMedGoogle Scholar
  15. 14.
    Colledge, K. I., Pezzulich, M. & Marsh, W. L. (1973): Anti-Fy5, an antibody disclosing a probable association between the Rhesus and Duffy blood group genes. Vox Sang. 24, 193–199.PubMedCrossRefGoogle Scholar
  16. 15.
    Cook, P. J. L., Page, B. M., Johnston, A. W., Stanford, W. K. & Gavin, J. (1978): Four further families informative for 1q and the Duffy blood group. Human gene mapping 4. Cytogenet. Cell Genet. 22, 378–380.PubMedCrossRefGoogle Scholar
  17. 16.
    Cutbush, M. & Mollison, P. L (1950): The Duffy blood group system. Heredity 4, 383–389.PubMedCrossRefGoogle Scholar
  18. 17.
    Cutbush, M., Mollison, P. L & Parkin, D. M. (1950): A new human blood group. Nature 165, 188.CrossRefGoogle Scholar
  19. 18.
    Golenda, C. F., Li, J. & Rosenberg, R. (1997): Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc. Natl. Acad. Sci. USA 94, 6786–6791.PubMedCrossRefGoogle Scholar
  20. 19.
    Hadley, T. J., David, P. H., Mcginniss, M. H. & Miller, L. H. (1984): Identification of an erythrocyte component carrying the Duffy blood group Fya antigen. Science 223, 597–599.PubMedCrossRefGoogle Scholar
  21. 20.
    Hadley, T. J., Lu, Z. H., Wasniowska, K., Martin, A. W., Peiper, S. C., Hesselgesser, J. & Horuk, R. (1994): Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J. Clin. Invest. 94, 985–991.PubMedCrossRefGoogle Scholar
  22. 21.
    Hadley, T. J. & Peiper, S. C. (1997): From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 89, 3077–3091.PubMedGoogle Scholar
  23. 22.
    Hausman, E., Dzik, W. & Blanchard, D. (1996): The red cell chemokine receptor is distinct from the Fy6 epitope. Transfusion 36, 421–425.PubMedCrossRefGoogle Scholar
  24. 23.
    Haynes, J. D., Dalton, J. P., Klotz, F. W., Mcginniss, M. H., Hadley, T. J., Hudson, D. E. & Miller, L. H. (1988): Receptor-like specificity of a Plasmodium knowiesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J. Exp. Med. 167, 1873–1881.PubMedCrossRefGoogle Scholar
  25. 24.
    Horuk, R., Chitnis, C. E., Darbonne, W. C., Colby, T. J., Rybicki, A., Hadley, T. J. & Miller, L. H. (1993): A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261, 1182–1184.PubMedCrossRefGoogle Scholar
  26. 25.
    Horuk, R., Zi-Xuan, W., Peiper, S. C. & Hesselgesser, J. (1994): Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J. Biol. Chem. 269, 17730–17733.PubMedGoogle Scholar
  27. 26.
    Ikin, E. W., Mourant, A. C., Pettenkofer, H. J. & Blumenthal, G. (1951): Discovery of the expected haemagglutinin, anti-Fyb. Nature 168, 1077.PubMedCrossRefGoogle Scholar
  28. 27.
    Issitt, P. D. (1985): The Duffy blood group system. In: Applied Blood Group Serology. Montgomery Scientific Publications, Miami, Florida, USA, pp. 278–288.Google Scholar
  29. 28.
    Iwamoto, S., Li, J., Omi, T., Ikemoto, S. & Kajii, E. (1996): Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 87, 378–385.PubMedGoogle Scholar
  30. 29.
    Iwamoto, S., Li, J., Sugimoto, N., Okuda, H. & Kajii, E. (1996): Characterization of the Duffy gene promoter: evidence for tissue-specific abolishment of expression in Fy(a-b-) of black individuals. Biochem. Biophys. Res. Commun. 222, 852–859.PubMedCrossRefGoogle Scholar
  31. 30.
    Iwamoto, S., Omi, T., Kajii, E. & Ikemoto, S. (1995): Genomic organization of the glycoprotein D gene: Duffy blood group FyaFyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85, 622–626.PubMedGoogle Scholar
  32. 31.
    Le Pennec, P. Y., Rouger, P., Klein, M. T., Robert, N. & Salmon, C. (1987): Study of anti-Fya in five black Fy(a-b-) patients. Vox Sang. 52, 246–249.PubMedCrossRefGoogle Scholar
  33. 32.
    Lewis, M., Kaita, H. & Chown, B. (1972): The Duffy blood group system in Caucasians. A further population sample. Vox Sang. 23, 523–527.PubMedCrossRefGoogle Scholar
  34. 33.
    Lisowska, E., Duk, M. & Wasniowska, K. (1983): Duffy antigens: observations on biochemical properties. In: Red Cell Membrane Glycoconjugates and Related Genetic Markers (J. P. Cartron, P. Rouger, and C. Salmon, eds.). Librairie Amette, Paris, pp. 87–96.Google Scholar
  35. 34.
    Lu, Z. H., Wang, Z. X., Horuk, R., Hesselgesser, J., Lou, Y. C., Hadley, T. J. & Peiper, S. C. (1995): The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J. Biol. Chem. 270, 26239–26245.PubMedCrossRefGoogle Scholar
  36. 35.
    Mallinson, G., Soo, K. S., Schall, T. J., Pisacka, M. & Anstee, D. J. (1995): Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fy7Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br. J. Haematol. 90, 823–829.PubMedCrossRefGoogle Scholar
  37. 36.
    Mason, S. J., Miller, L. H., Shiroishi, T, Dvorak, J. A. & Mcginniss, M. H. (1977): The Duffy blood group determinants: their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. Br. J. Haematol. 36, 327–335.PubMedCrossRefGoogle Scholar
  38. 37.
    Masouredis, S. P., Sudora, E., Mahan, L. & Victoria, E. L. (1980): Quantitative immunoferritin microscopy of Fya, Fyb, Jka, U, and Dib antigen site numbers on human red cells. Blood 56, 969–977.PubMedGoogle Scholar
  39. 38.
    Matthew, S., Chaudhuri, A., Murty, V. V. & Pogo, A. O. (1994): Confirmation of Duffy blood group antigen locus (FY) at 1q22→q23 by fluorescence in situ hybridization. Cytogenet. Cell Genet. 67, 68.CrossRefGoogle Scholar
  40. 39.
    Miller, L. H., Mason, S. J., Clyde, D. F. & Mcginniss, M. H. (1976): The resistance factor to Plasmodium vivax in blacks. The Duffy blood group genotype, FyFy. N. Engl. J. Med. 295, 302–304.PubMedCrossRefGoogle Scholar
  41. 40.
    Miller, L H., Mason, S. J., Dvorak, J. A., Mcginniss, M. H. & Rothmann, J. K. (1975): Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189, 561–563.PubMedCrossRefGoogle Scholar
  42. 41.
    Miller, L. H., Shiroishi, T., Dvorak, J. A., Durocher, J. R. & Schrier, B. K. (1975): Enzymatic modification of the erythrocyte membrane surface and its effect on malarial merozoite invasion. J. Mol. Med. 1, 55–63.Google Scholar
  43. 42.
    Moore, S., Woodrow, C. F. & Mcclelland, D. B. L. (1982): Isolation of membrane components associated with human red cell antigens Rh(D), (c), (E), and Fya. Nature 295, 529–531.PubMedCrossRefGoogle Scholar
  44. 43.
    Moulds, J. M., Hayes, S. & Wells, T. D. (1998): DNA analysis of Duffy genes in American blacks. Vox Sang. 74, 248–252.PubMedCrossRefGoogle Scholar
  45. 44.
    Neote, K., Mak, J. Y, Kolakowski, L. F. & Schall, T. J. (1994): Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 84, 44–52.PubMedGoogle Scholar
  46. 45.
    Nichols, M. E., Rubinstein, P., Barnwell, J., Rodriguez De Cordoba, S. & Rosenfield, R. E. (1987): A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plamodium vivax. J. Exp. Med. 166, 776–785.PubMedCrossRefGoogle Scholar
  47. 46.
    Olsson, M. L., Smythe, J. S., Hansson, C., Poole, J., Mallinson, Q., Jones, J., Avent, N. D. & Daniels, G. (1998): The Fyx phenotype is associated with a missense mutation in the Fyb allele predicting Arg89Cys in the Duffy glycoprotein. Br. J. Haematol. 103, 1184–1191.PubMedCrossRefGoogle Scholar
  48. 47.
    Palatnik, M. & Rowe, A. W. (1984): Duffy and Duffy-related human antigens in primates. J. Hum. Evolut. 13, 173–175.CrossRefGoogle Scholar
  49. 48.
    Parasol, N., Reid, M., Rios, M., Castilho, L., Harari, I. & Kosower, N. S. (1998): A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood 92, 2237–2243.PubMedGoogle Scholar
  50. 49.
    Peiper, S. C. M., Wang, Z. X., Neote, K., Martin, A. W., Showell, H. J., Conklyn, M. J., Ogborne, K., Hadley, T. J., Lu, Z. H., Hesselgesser, J. & Horuk, R. (1995): The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J. Exp. Med. 181, 1311–1317.PubMedCrossRefGoogle Scholar
  51. 50.
    Race, R. R. & Sänger, R. (1975): The Duffy blood group. In: Blood Groups in Man. Blackwell Scientific Publications, Oxford, pp. 350–363.Google Scholar
  52. 51.
    Riwom, S., Janvier, D., Navenot, J. M., Benbunan, M., Müller, J. Y. & Blanchard, D. (1994): Production of a new murine monoclonal antibody with Fy6 specificity and characterization of the immunopurified N-glycosylated Duffy-active molecule. Vox Sang. 66, 61–67.PubMedCrossRefGoogle Scholar
  53. 52.
    Tanner, M. J. A., Anstee, D. J., Mallinson, G., Ridgwell, K., Martin, P. G., Avent, N. D. & Parsons, S. F. (1988): Effect of endoglycosidase F-peptidyl N-glycosidase F preparations on the surface components of the human erythrocyte. Carbohydr. Res. 178, 203–212.PubMedCrossRefGoogle Scholar
  54. 53.
    Toivanen, P. & Hirvonen, T. (1973): Antigens Duffy, Kell, Kidd, Lutheran, and Xga on fetal red cells. Vox Sang. 24, 372–376.PubMedCrossRefGoogle Scholar
  55. 54.
    Tournamille, C., Colin, Y, Cartron, J. P. & Le Van Kim, C. (1995): Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10, 224–228.PubMedCrossRefGoogle Scholar
  56. 55.
    Tournamille, C., Le Van Kim, C., Gane, P., Blanchard, D., Proudfoot, A. E., Cartron, J. P. & Colin, Y (1997): Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J. Biol. Chem. 272, 16274–16280.PubMedCrossRefGoogle Scholar
  57. 56.
    Tournamille, C., Le Van Kim, C., Gane, P., Cartron, J. P. & Colin, Y (1995): Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum. Genet. 95, 407–410.PubMedCrossRefGoogle Scholar
  58. 57.
    Tournamille, C., Le Van Kim, C., Gane, P., Le Pennec, P. Y, Roubinet, F., Babinet, J., Cartron, J. P. & Colin, Y (1998): Arg89Cys substitution results ins very low membrane expression of the Duffy antigen/receptor for chemokines in Fy” individuals. Blood 92, 2147–2156.PubMedGoogle Scholar
  59. 58.
    Wasniowska, K., Blanchard, D., Janvier, D., Wang, Z. X., Peiper, S. C., Hadley, T. J. & Lisowska, E. (1996): Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol. Immunol. 33, 917–923.PubMedCrossRefGoogle Scholar
  60. 59.
    Williams, D., Johnson, C. L. & Marsh, W. L. (1981): Duffy antigen changes on red blood cells stored at low temperature. Transfusion 21, 357–359.PubMedCrossRefGoogle Scholar
  61. 60.
    Zhao-Hai, L., Zi-Xuan, W., Horuk, R., Hesselgesser, J., Yang-Chun, L., Hadley, T. J. & Peiper, S. C. (1995): The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J. Biol. Chem. 270, 26239–26245.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • Helmut Schenkel-Brunner
    • 1
  1. 1.Institut für Medizinische BiochemieUniversität WienViennaAustria

Personalised recommendations